ELEV
Elevation Oncology
ELEV
ELEV
Delisted
ELEV was delisted on the 22nd of July, 2025.
41 hedge funds and large institutions have $18.6M invested in Elevation Oncology in 2023 Q3 according to their latest regulatory filings, with 7 funds opening new positions, 13 increasing their positions, 7 reducing their positions, and 5 closing their positions.
Holders
41
Holders Change
+2
Holders Change %
+5.13%
% of All Funds
0.65%
Holding in Top 10
3
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-25%
% of All Funds
0.05%
New
7
Increased
13
Reduced
7
Closed
5
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
1 |
1
Millennium Management
New York
|
$2.01M |
2 |
2
Bank of America
Charlotte,
North Carolina
|
$102K |
3 |
3
UBS Group
Zurich,
Switzerland
|
$82.6K |
4 |
4
Geode Capital Management
Boston,
Massachusetts
|
$153K |
5 |
5
Two Sigma Advisers
New York
|
$50.9K |